966
Views
22
CrossRef citations to date
0
Altmetric
Methods in Addiction

Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users

, PhD, , PhD, , PhD & , PhD
Pages 19-23 | Received 04 May 2017, Accepted 17 Aug 2017, Published online: 23 Oct 2017

References

  • Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, Sellman JD. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010 Jul 1;110(1–2):137–43. doi:10.1016/j.drugalcdep.2010.02.017.
  • Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003 Sep 1;22(3):309–15. doi:10.1080/0959523031000154454.
  • Annaheim B, Rehm J, Gmel G. How to screen for problematic cannabis use in population surveys. Eur Addict Res. 2008 Jun 27;14(4):190–97. doi:10.1159/000141643.
  • Bonn-Miller MO, Heinz AJ, Smith EV, Bruno R, Adamson S. Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: the Cannabis Use Disorder Identification Test Short-Form. Cannabis and Cannabinoid Res. 2016 Dec 1;1(1):252–61. doi:10.1089/can.2016.0022.
  • Stone AL, Becker LG, Huber AM, Catalano RF. Review of risk and protective factors of substance use and problem use in emerging adulthood. Addict Behav. 2012 Jul 31;37(7):747–75. doi:10.1016/j.addbeh.2012.02.014.
  • Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008 May 1;9(4):444–59. doi:10.1111/j.1526-4637.2007.00370.x.
  • Wallace MS, Ware MA. Medicinal marijuana: here to stay and time to take responsibility. Clin J Pain. 2015 Nov 1;31(11):931–32. doi:10.1097/AJP.0000000000000217.
  • Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 2017 Mar;1(172):9–13. doi:10.1016/j.drugalcdep.2016.11.030.
  • Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014 Jun 1;55(6):791–802. doi:10.1111/epi.12631.
  • Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F. The medicinal use of cannabis and cannabinoids—an international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013 Jul 1;45(3):199–210. doi:10.1080/02791072.2013.805976.
  • Bonn-Miller MO, Babson KA, Vandrey R. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 2014 Mar;1(136):162–65. doi:10.1016/j.drugalcdep.2013.12.008.
  • Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv. 2012 Nov;9(4):404–16. doi:10.1037/a0027622.
  • Roy-Byrne P, Maynard C, Bumgardner K, Krupski A, Dunn C, West II, Donovan D, Atkins DC, Ries R. Are medical marijuana users different from recreational users? The view from primary care. Am J Addict. 2015 Oct 1;24(7):599–606. doi:10.1111/ajad.12270.
  • Bruno R, Marshall S, Adamson S. Screening For Dsm-5 Cannabis Dependence Using The Cannabis Use Disorders Identification Test–Revised. Drug Alcohol Rev. 2013 Nov 1;32:28.
  • Rosseel Y, Oberski D, Byrnes J, Vanbrabant L, Savalei V, Merkle E, Hallquist M, Rhemtulla M, Katsikatsou M, Barendse M, et al. Lavaan R. Package.
  • Brown TA. Confirmatory Factor Analysis for Applied Research. New York: NY: Guildford Publictions;2014 Dec
  • Tabachnick BG, Fidell LS. Using Multivariate Statistics. 5th ed. Boston, MA: Pearson; 2001.
  • Loflin MJ, Earleywine M Beliefs about marijuana act as risk/protective factors against problem development. Poster presented at: the European Harm Reduction Conference; 2014 May; Basel, Switzerland.
  • Thake J, Davis CG. Assessing problematic cannabis use. Addict Res Theory. 2011 Oct 1;19(5):448–58. doi:10.3109/16066359.2010.545154.
  • Annaheim B, Scotto TJ, Gmel G. Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of Item Response Theory. Int J Methods Psychiatr Res. 2010;19(3):142–55. doi:10.1002/mpr.v19:3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.